IMS revises predicted global pharma growth rate
Territory by territory, the US market is set to endure the worst growth rate of 2009, with IMS predicting -1 to -2% growth there. Europe fares a little better with 2Ð3% growth, but everywhere will be left standing by the growth rate predicted for the seven 'pharmerging markets' , which are collectively predicted to grow by a whopping 13-14%. [more...]
|
|
|
